Vice President of Client Solutions
David is currently serving as the Vice President of Client Solutions at Rockland Immunochemicals and has more than 15 years of academic and industrial experience. David oversees custom projects and contract research services and works to bridge client needs and laboratory efforts with biotech, large pharmaceutical companies, and academic laboratories. David works with a team of world-class Rockland scientists and technicians in custom polyclonal and monoclonal antibody generation, immunoassay development, and molecular biology services. Additionally, he leads Rockland’s efforts on government-funded SBIR grants and contracts using innovation to create a lasting impact on healthcare problems.
David has a Doctorate in Microbiology and Immunology from the University of Virginia and received postdoctoral training in Biochemistry and Biophysics at the University of Pennsylvania in Philadelphia. David has worked extensively in utilizing protein structural and bioinformatics analyses to design highly specialized research antibodies.
Facts About Me
- I have a Doctorate in Microbiology and Immunology from the University of Virginia
- I received postdoctoral training in Biochemistry and Biophysics at the University of Pennsylvania in Philadelphia
- I have utilized protein structural and bioinformatics analyses to design highly specialized research antibodies
- I enjoy coaching youth girls lacrosse for my daughters
- I grow a variety of peppers and like to experiment creating different hot sauces
Top Skills
- Antibody Generation
- Assay Development
- Microbiology
- Protein Biochemistry
- Protein Expression & Purification
Articles
-
25 years of NF-κB at Rockland
Together with Leica Microsystems, we take a look at the antibodies we produced against NF-κB and the phosphorylated forms, subunits, inhibitors and NLS sites of NF-κB using new technologies. -
Detection of Akt Migration Using STED Nanoscopy
In this poster, Rockland and Leica Microsystems have jointly analyzed the sub-cellular localization of Akt using both standard confocal microscopy and high resolution STED nanoscopy. -
Development of an improved standardized immunoassay for HCP detection using 2D electrophoresis and western blotting system
This poster presents the development of a 2D SDS-PAGE and Western blotting method in partnership with Bio-Rad Laboratories to validate the efficacy of immunocoverage for a novel anti-HCP polyclonal antibody generated against an E.coli HCP lysate. -
Enhanced HCP Coverage Analysis utilizing Multiplexed 2D Electrophoresis
Evaluate the coverage of Rockland's generic anti-CHO-HCP antibody by 2D-PAGE separation using two experimental methods. -
Enhanced Multiplex Western Blotting
Enhanced multiplex fluorescent western blotting protocol for the production of immunoblot on PVDF membrane and determining limit of fluorescent detection. -
H6D Polymorphism Specific Detection of NAG1 in Human Serum
The goal is to create a commercial ELISA with low background and high signal-to-noise ratio that's capable of detecting serum NAG1 at concentrations of ≥25 pg/mL. -
HCP Analysis of a Small Drug-Protein in Process Sample
Poster exploring a combination of analysis methods enabling maximum coverage and information details on each HCP. -
Improved Western Blot Assays Using BlotCycler Automated Wash System
Comparing traditional Western blotting and automatic Western blotting by using Rockland's DyLight™ fluorochrome conjugated secondary antibodies. -
Multi-assay Functional Antibodies in HCP Detection
This poster presents methods and data for HCP antibody production using antigens from different hosts using different HCP sample types. -
Novel Multiplex Test for Lyme Disease
This poster presents the preliminary data in Rocklands efforts to develop a POC testing device for Lyme Disease.